Bio Essence Corp

OTCPK:BIOE (USA)  
$ 0.90 -0.28 (-23.73%) 03:56 PM EST
At Loss
Market Cap:
$ 34.21M
Enterprise V:
$ 46.89M
Volume:
153.69K
Avg Vol (2M):
140.25K
Trade In:
Volume:
153.69K
At Loss
Avg Vol (2M):
140.25K

Business Description

Bio Essence Corp
NAICS : 325412 SIC : 2834
ISIN : US09090C1053
Compare
Compare
Traded in other countries / regions
BIOE.USA
IPO Date
2022-03-30
Description
Bio Essence Corp is an herbal health, diet, and nutrition company. The Company's mission is to provide herbal health, diet, and vitamin nutritional supplements. It develops traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. It also offers special formulated dietary supplements and medical food.
Name Current Vs Industry Vs History
Equity-to-Asset -2.04
Debt-to-Equity -1.42
Debt-to-EBITDA -3.42
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.31
Distress
Grey
Safe
Beneish M-Score 80.71
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 26.05
9-Day RSI 36.6
14-Day RSI 42.1
6-1 Month Momentum % -33.33
12-1 Month Momentum % -33.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.31
Quick Ratio 0.31
Days Inventory 573.05
Days Sales Outstanding 26.29
Days Payable 233.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.8
Shareholder Yield % 3.84
Name Current Vs Industry Vs History
Gross Margin % 52.61
Operating Margin % -320.85
Net Margin % -270.14
FCF Margin % -457.82
ROA % -33.72
ROIC % -19.48
ROC (Joel Greenblatt) % -44.5

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 149.97
EV-to-EBIT -72.81
EV-to-EBITDA -78.67
EV-to-Revenue 222.21
EV-to-FCF -48.54
Earnings Yield (Greenblatt) % -1.37
FCF Yield % -2.82